1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Sanotize Research and Development corp.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection Nitric Oxide, Nasal spray with isotonic saline - SARS-CoV-2 Infection | Phase 3 | Terminated | Sanotize Research and Development corp. | 1389 | 2021-11-20 | 2025-09-25 |
| Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19 Nitric Oxide - SARS-CoV-2 Infection | Phase 3 | Completed | Sanotize Research and Development corp. | 306 | 2021-11-01 | 2022-10-31 |
COVID-19 (2)
Nasal Sprays (2) · Nitric Oxide (2)
Canada (1) · India (1) · Sri Lanka (1)